Takeda Facing Trial Over Actos in California As Evidence Emerges That Exec’s Hid Risks in 2003 To Protect Sales
In 1999 the FDA approved a drug developed by Takeda Pharmaceuticals for the treatment of Type 2 diabetes. Actos, from the class of drugs known as thiazolidinediones is said to increase the sensitivity to insulin. Fourteen years later, the affects of this drug are presenting themselves. In 2010, the FDA came out with a safety […]
Takeda Facing Trial Over Actos in California As Evidence Emerges That Exec's Hid Risks in 2003 To Protect Sales
In 1999 the FDA approved a drug developed by Takeda Pharmaceuticals for the treatment of Type 2 diabetes. Actos, from the class of drugs known as thiazolidinediones is said to increase the sensitivity to insulin. Fourteen years later, the affects of this drug are presenting themselves. In 2010, the FDA came out with a safety […]
